Home » MEDTRONIC RECEIVES FDA APPROVAL FOR ITS CONCERTO/VIRTUOSO LINE OF IMPLANTABLE CARDIAC DEVICES
MEDTRONIC RECEIVES FDA APPROVAL FOR ITS CONCERTO/VIRTUOSO LINE OF IMPLANTABLE CARDIAC DEVICES
Medtronic Inc. announced that it received FDA approval of its Concerto/Virtuoso line of implantable cardiac devices, its next generation of cardiac rhythm disease management products.
Trading
Markets Live
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May